Abstract
We treated 137 patients with well-differentiated thyroid carcinoma at our hospital from 2002 to 2012. This paper clarifies the high-risk group based on prognostic factors of recurrence.
The 5-year survival rate for patients with thyroid carcinoma was 94.9%. Recurrence occurred in 25 cases (18.2%). The factors of patient’s age and sex were not related to recurrence. The factors of disease, vein invasion, extracapsular spread and lymph node metastasis for D2 area made significant independent contributions.
We must determine the course of treatment of patients with prognostic factors of recurrence carefully. We also need to follow the patients carefully, such as a CT scan every six months and ultrasound every three months.
